1-2 of 2
Tomoki Naoe, MD, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MS4A1 (CD20) Gene Expression Is Down-Regulated by Recruiting the Histone Deacetylase Protein Complex to the Promoter in the CD20-Negative B-Lymphoma Cells After Treatment with Rituximab.

Takumi Sugimoto, MD, Akihiro Tomita, MD, Ph.D., Junji Hiraga, MD, Ph.D., Kazuyuki Shimada, MD, Ph.D., Hitoshi Kiyoi, MD, Ph.D., Tomohiro Kinoshita, MD, Ph.D., Tomoki Naoe, MD, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1286.
https://doi.org/10.1182/blood.V114.22.1286.1286
Published: 2009
Journal Articles

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

Itsuro Jinnai, MD, Tohru Sakura, MD, Motohiro Tsuzuki, MD, Yasuhiro Maeda, MD, PhD, Noriko Usui, MD, Masayuki Kato, MD, Hirokazu Okumura, MD, PhD, Yasunori Ueda, MD, Yuji Kishimoto, MD, Fumiharu Yagasaki, MD, Jin Takeuchi, MD, Masako Iwanaga, MD, Yasushi Miyazaki, MD, Shuichi Miyawaki, MD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, Ph.D., Ryuzo Ohno, MD
Journal: Blood
Blood (2009) 114 (22): 4334.
https://doi.org/10.1182/blood.V114.22.4334.4334
Published: 2009